Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;15(3):e70265.
doi: 10.1002/ctm2.70265.

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression

Affiliations

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression

Jacklyn Liu et al. Clin Transl Med. 2025 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Patterns of B7‐H3 staining observed in oropharyngeal cancer specimens: (A) Representative membranous and cytoplasmic staining, as seen across most cases, where positive staining was observed predominantly in cells at the periphery, adjacent to the stroma and furthest from the centre of tumour nests. (B) Positive staining of a well‐differentiated tumour, where expression is observed in the non‐keratinising cells at the periphery with negative expression in the keratinised interior of the tumour nest. (C) Positive staining of tumour‐associated lymphovascular endothelium. (D) Positive staining in the basal keratinocytes of the normal epithelium. (E, F) Boxplot with medians indicated of B7‐H3 tumoural and stromal H‐score relative to semi‐quantitative grading with statistically significant differences between groups for both the tumour (< .001) and stroma score (p < .001).

References

    1. Lechner M, Liu J, Masterson L, Fenton TR. HPV‐associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306‐327. doi:10.1038/s41571-022-00603-7 - DOI - PMC - PubMed
    1. Lechner M, Jones OS, Breeze CE, Gilson R. Gender‐neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness. Lancet Infect Dis. 2019;19(2):131‐132. doi:10.1016/S1473-3099(18)30802-8 - DOI - PubMed
    1. Lechner M, Masterson L, Mermelstein S, et al. Oropharyngeal cancer: lack of human papillomavirus awareness and economic burden in the United States. Clin Transl Med. 2024;14(11):e70062. doi:10.1002/ctm2.70062 - DOI - PMC - PubMed
    1. Lechner M, Fenton TR. The genomics, epigenomics, and transcriptomics of HPV‐associated oropharyngeal cancer: understanding the basis of a rapidly evolving disease. Adv Genet. 2016;93:1‐56. doi:10.1016/bs.adgen.2015.12.001 - DOI - PubMed
    1. Castriconi R, Dondero A, Augugliaro R, et al. Identification of 4Ig‐B7‐H3 as a neuroblastoma‐associated molecule that exerts a protective role from an NK cell‐mediated lysis. Proc Nat Acad Sci USA. 2004;101(34):12640‐12645. doi:10.1073/pnas.0405025101 - DOI - PMC - PubMed

LinkOut - more resources